2018-06-07T13:56:46-05:00 2017-09-30 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2016-10-01 840865803 NATIONAL MARROW DONOR PROGRAM % AMY RONNEBERG NATI 7634065800 500 N 5th St Minneapolis MN 554011206 AMY RONNEBERG CFO 7634068694 2018-06-04 true Daniel V Romano P00504182 4142898200 2016 2022-09-23 18:48:47Z BE THE MATCH C Randal Mills 500 N 5th St Minneapolis MN 554011206 391630568 false X WWW.BETHEMATCH.ORG X 1981 CO WE SAVE LIVES THROUGH CELLULAR THERAPY. 19 19 1058 4115 -21785 -26460 51087431 53550922 339752301 335484500 994576 1924761 126098 46716 391960406 391006899 3350845 2864615 0 0 86333230 90429301 0 0 837670 280802116 271789496 370486191 365083412 21474215 25923487 325206218 361819626 149830555 149393689 175375663 212425937 X FOR PATIENTS WITH BLOOD CANCERS LIKE LEUKEMIA, LYMPHOMA, OR OTHER LIFE-THREATENING BLOOD DISORDERS, THERE IS HOPE FOR A CURE THROUGH MARROW TRANSPLANTATION. THE FIRST STEP IS TO FIND A MATCHED DONOR, BUT 70% PERCENT OF PATIENTS DO NOT HAVE A SUITABLY MATCHED DONOR IN THEIR FAMILY AND DEPEND ON OUR BE THE MATCH REGISTRY TO FIND A MARROW DONOR. WITH THE SUPPORT OF OUR CONTRIBUTORS, EACH YEAR WE: -Facilitate more marrow and cord blood transplants -grow and diversify the world's largest and most diverse donor registry -support patients and their families before, during, and after tansplant -conduct research and education to expand treatment and improve outcomes -engage the public in our life-saving mission. AS THE WORLD'S LEADING NONPROFIT ORGANIZATION FOCUSED ON SAVING LIVES THROUGH CELLULAR THERAPY, BE THE MATCH CONTINUES TO IMPROVE ACCESS TO TRANSPLANT BY LEADING EFFORTS TO REMOVE BARRIERS TO TREATMENT AND STRENGTHEN OUR ABILITY TO MEET THE GROWING NEED. THANKS TO OUR COMMUNITY OF DONOR false false 220855063 335119607 TRANSPLANT - IN 1987, THE FOUNDERS OF NATIONAL MARROW DONOR PROGRAM (NMDP) MADE A COMMITMENT TO INCREASE ACCESS TO TRANSPLANTS AND TO FIND PEOPLE WILLING TO DONATE AND SUPPORT RESEARCH TO EXTEND AND IMPROVE LIVES. NMDP'S MISSION STATEMENT - "WE SAVE LIVES THROUGH CELLULAR THERAPY" - CAPTURES AND COMMUNICATES THE REASON FOR NMDP'S EXISTENCE. EACH YEAR, NMDP INCURS PROGRAM MEDICAL EXPENSES RELATED TO MATCHING UNRELATED DONORS WITH PATIENTS. IN FISCAL YEAR 2017, MORE THAN 16,400 U.S. AND INTERNATIONAL SEARCHES OF THE BE THE MATCH REGISTRY WERE CONDUCTED ON BEHALF OF PATIENTS SEEKING A MATCHING DONOR OR CORD BLOOD UNIT. NEARLY 6,100 PATIENTS WENT ON TO RECEIVE A TRANSPLANT SINCE BEGINNING OPERATIONS. NMDP HAS FACILITATED MORE THAN 86,000 MARROW AND CORD BLOOD TRANSPLANTS FOR PATIENTS. 40087465 112470 RECRUITMENT - THE BE THE MATCH REGISTRY PROVIDES THE MOST DIVERSE LISTING OF POTENTIAL DONORS AND CORD BLOOD UNITS IN THE WORLD. WITH 19 MILLION POTENTIAL DONORS AND 249,000 CORD BLOOD UNITS, OUR GROWING REGISTRY IS HELPING MORE PATIENTS THAN EVER BEFORE GET THE TRANSPLANT THEY NEED. In FICASL YEAR 2017, 493,000 new potential donors were added to the be the match registry. Although there are millions on the registry, patients sometimes still can not find a match. This is due in part to the patient's ethnic background. On average, a patient's likelihood of finding a match on THE BE THE MATCH REGISTRY RANGES FROM 19% TO 80% DEPENDING ON THE ETHNIC BACKGROUND. SOME ETHNIC GROUPS HAVE MORE COMPLEX TISSUE TYPES THAN OTHERS, SO A PERSON'S BEST CHANCE OF FINDING A DONOR IS WITH SOMEONE OF THE SAME ETHNIC BACKGROUND. THE IMPORTANCE OF INCREASING DIVERSITY ON THE REGISTRY IS AN ORGANIZATION GOAL AND PRIORITY AT BE THE MATCH. 34149488 239055 40808 RESEARCH - Be the Match CONDUCTS RESEARCH THROUGH THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH), A COMBINED RESEARCH PROGRAM OF NMDP AND THE MEDICAL COLLEGE OF WISCONSIN. THE CIBMTR FACILITATES CRITICAL, CUTTING-EDGE RESEARCH THAT HAS LED TO INCREASED SURVIVAL AND AN ENRICHED QUALITY OF LIFE FOR THOUSANDS OF PATIENTS WORLDWIDE. NMDP facilitates extensive research and scientifIc services for improving outcomes throuGh clinical research. This work includes establishing and maintaining an extensive database for researchers, conducting observational studies, and planning and facilitating clinical trials that assess trends and therapies. During fiscal year 2017, approximately $34 million was used to fund research programs to improve the marrow donation process and advance transplant science. 11976648 2625560 211615 PUBLIC AWARENESS 11976648 2625560 211615 307068664 true true false true false false false false false false true false false false true true false true false false true true false false false false false true false true true false false false false false false false false false false false false false false true true true true false false true 1314 0 true 1058 true true true true CJ false false false false false false false false X 19 19 true false false false false false false true true false false true true true true true true true true false AL AR CA CT FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X AMY RONNEBERG 7634068694 500 N 5TH STREET MINNEAPOLIS MN 554011206 X Lynn Abrahamsen Chair 1.0 0.0 X 0 0 0 John Wingard Immediate Past Chair 1.0 0.0 X 0 0 0 David Porter Vice Chair 1.0 0.0 X 600 0 0 Yvonne Ybarra Council Chair - thru 1/2017 1.0 0.0 X 0 0 0 Gary Goldstein Council Chair - as of 2/2017 1.0 0.0 X 0 0 0 Pankaj Kamani Secretary 1.0 0.0 X 0 0 0 Daniel Arndt Director 1.0 0.0 X 0 0 0 Jennifer Jones Austin Director - thru 10/2016 1.0 0.0 X 0 0 0 Ann Berkey Director 1.0 0.0 X 0 0 0 Melinda Caltabiano Director 1.0 0.0 X 0 0 0 Michael Davenport Director 1.0 0.0 X 0 0 0 Uri Herzberg Director 1.0 0.0 X 0 0 0 Michael Lang Director 1.0 0.0 X 0 0 0 John McMannis Director - thru 5/2017 1.0 0.0 X 0 0 0 Miguel-Angel Perales Director 1.0 0.0 X 0 0 0 Brian Reithel Director 1.0 0.0 X 0 0 0 Harpreet Sandhu Director 1.0 0.0 X 0 0 0 David Schubert Director 1.0 0.0 X 0 0 0 Robert Soiffer Director 1.0 0.0 X 0 0 0 Abigail West Director 1.0 0.0 X 0 0 0 Lori White Director 1.0 0.0 X 0 0 0 Kimberly Kasow Wichlan Director 1.0 0.0 X 0 0 0 Jeffrey Chell CEO - thru 6/2017 48.0 2.0 X 977403 0 46084 C Randal Mills CEO - as of 7/2017 48.0 2.0 X 0 0 0 Dennis Confer Chief Medical Officer 48.0 2.0 X 491385 0 55516 Amy Ronneberg Chief Financial Officer 49.0 1.0 X 444893 0 28160 Karen Dodson Chief Operations Officer 49.5 0.5 X 384168 0 45558 Michael McCullough Chief Information Officer 45.0 5.0 X 376509 0 52793 Michael Boo CSO - thru 4/2017 49.0 1.0 X 400808 0 46059 Brian Lindberg Chief Legal Officer 49.0 1.0 X 392359 0 53023 John Miller VP & Sr. Medical Director 50.0 0.0 X 376137 0 37637 Linda Burns VP & Medical Dir., Research 50.0 0.0 X 346460 0 45401 Tracy Schmidt Chief Human Resources Officer 49.0 1.0 X 277859 0 55024 G Barry Huff Former Key Employee 0.0 0.0 X 212953 0 0 4681534 0 465255 134 true true false SPACE 150 INC 212 THIRD AVENUE NORTH STE 150 MINNEAPOLIS MN 55401 MARKETING CONSULTING 2932428 ORACLE AMERICA INC 500 ORACLE PARKWAY REDWOOD PARKWAY CA 64065 IT SERVICE 2067647 THE EMMES CORPORATION 401 N WASHINGTON STREET STE 700 ROCKVILLE MD 20850 DATA COLLECTION 1637355 BERGHUIS AND HUNT 910 1/2 MAIN STREET HOPKINS MN 55343 IT SERVICE 1455885 Datalink 10050 CROSSTOWN CIRCLE SUITE 500 EDEN PRAIRIE MN 55344 IT SERVICE 1370286 75 4672060 42113022 6765840 53550922 SEARCH/PROCUREMENT REVENUE 900099 335484500 335484500 335484500 2131232 2131232 0 0 325702 353075 0 -27373 -27373 -27373 57123 7000 57121 213473 2 -206473 -206471 -206471 0 0 0 0 0 0 0 0 0 PARKING LOT RENTAL 900099 64255 64255 AUDITORIUM/RENTAL SERVICES 900099 9834 5588 4246 74089 391006899 335484500 -21785 1993262 2625560 2625560 0 239055 239055 0 3234261 3234261 0 69228816 50952320 18171795 104701 3947221 2871665 1071377 4179 8586705 5547705 3030318 8682 5432298 3946428 1477968 7902 0 363103 363103 169999 169999 370272 370272 0 57834 57834 17540836 14186717 2687306 666813 8642154 7332396 1304970 4788 3351096 2084842 1232204 34050 8078092 4395439 3682653 0 4909787 478880 4430907 4027097 3104112 918650 4335 0 248472 164428 84044 2923807 2923807 0 19770371 9188640 10581731 806961 140586 666137 238 MEDICAL SERVICES EXPENSES 170752612 170752612 DONOR RECRUITMENT SERVICES 19641825 19641825 FORMS COMPLETION & RESEARCH 8723627 8723627 INTERCOMPANY ALLOCATIONS -27373 -27373 1438924 691827 745115 1982 365083412 307068664 57177078 837670 40285971 65615083 20072820 21226498 1153418 2450276 55829730 49666745 0 0 0 0 0 0 0 0 5478485 5506774 189566252 82404754 113265907 107161498 84708389 98728783 0 0 0 5000000 0 0 4411498 6463969 325206218 361819626 60094003 62249261 0 0 4024138 9142849 24205000 18310000 0 0 0 0 0 0 0 0 61507414 59691579 149830555 149393689 X 175375663 212425937 0 0 0 0 175375663 212425937 325206218 361819626 X 25923487 5326787 5800000 X false true X true true true X 54907215 51722897 54831424 51087431 53550922 266099889 332541177 331815199 340231303 339752301 335484500 1679824480 0 0 0 387448392 383538096 395062727 390839732 389035422 1945924369 0 0 0 1945924369 1813112 1907349 1845845 1773618 2199733 9539657 0 1813112 1907349 1845845 1773618 2199733 9539657 23596 23596 0 389261504 385445445 396908572 392636946 391235155 1955487622 0.99511 0.99548 0.00488 0.00450 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 426631 426631 426631 426631 364656781 377356445 365083412 377783076 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 627520 683160 440463 426631 2177774 250000 250000 250000 250000 1000000 1500000 60208870 7318205 52890665 6244089 2026045 4218044 27520334 14056078 13464256 95592959 59004426 36588533 107161498 0 LONG TERM CAPITAL LEASE 55997631 DEFERRED COMPENSATION PAYABLE 3693947 59691578 X Organization's Liability for Uncertain Tax Positions under ASC 740 Schedule D, Part X, Line 2 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT THE PROGRAM AND BTMF ARE TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE NOT-FOR-PROFIT STATUS OF THE PROGRAM AND BTMF ARE CONSIDERED TAX POSITIONS UNDER FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES. THE ORGANIZATION FOLLOWS THE ACCOUNTING STANDARDS FOR CONTINGENCIES IN EVALUATING UNCERTAIN TAX POSITIONS. THIS GUIDANCE PRESCRIBES RECOGNITION THRESHOLD PRINCIPLES FOR THE FINANCIAL STATEMENT RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN ON A TAX RETURN THAT ARE NOT CERTAIN TO BE REALIZED. NO LIABILITY HAS BEEN RECOGNIZED BY THE ORGANIZATION FOR UNCERTAIN TAX POSITIONS AS OF SEPTEMBER 30, 2017 OR 2016. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE AUTHORITIES. BTMB is treated as a disregarded entity for income tax reporting purposes. As such, BTMBs income, losses and credits are included in the tax return of its sole member and parent, NMDP. BTMBTS is a regarded entity for tax purposes and files a separate tax return. CLR is an exempted company operating subject to the Companies Law (Revised) of Cayman Islands and is included in the tax return of NMDP. true East Asia and the Pacific Program Services Medical 3006810 Europe (Including Iceland and Greenland) Program Services Medical 37591258 Middle East and North Africa Program Services Medical 2691415 North America Program Services Medical 1842779 Russia and the Newly Independent States Program Services Medical 21851 South America Program Services Medical 2247251 South Asia Program Services Medical 574525 Sub-Saharan Africa Program Services Medical 119844 Central America and the Caribbean Program Services Medical 1403658 Central America and the Caribbean 1 Program Services Captive Insurance 926243 1 1 50425634 50425634 Europe (Including Iceland and Greenland) RESEARCH 239055 WIRE FMV 1 true false true false false true Procedure for Monitoring Use of Grant Funds Outside U.S. Schedule F, Part I, Line 2 International transplant centers throughout the world work in affiliation with the National Marrow Donor Program to find donors for the patients in need. Progress reports are submitted by research scientists for NMDP's review. if the progress is satisfactory, funds are distributed to the scientists. If no progress report is submitted or the progress is deemed unsatisfactory, no funds will be distributed. Total Expenditures by Region Schedule F, Part I, Line 3 The total expenditures by region calculated amount equals the checks that accounts payable cut during FY17. true ONCOLOGY NURSING SOCIETY PO BOX 3500 PITTSBURGH PA 15230 251410081 501(C)(3) 6710 CONFERENCE SPONSOR SICKLE CELL COMMUNITY CONSORTIUM 2265 LEXINGTON LANE CUMMING GA 30040 474771677 501(C)(3) 14350 CONFERENCE SPONSOR SICKLE CELL DISEASE ASSOC OF AMERICA 3700 KOPPERS ST BALTIMORE MD 21227 237175985 501(C)(3) 20000 CONFERENCE SPONSOR THE LEUKEMIA AND LYMPHOMA SOCIETY 651 WERST WASHINGTON BLVD CHICAGO IL 60661 135644916 501(C)(3) 6000 CONFERENCE SPONSOR AMERICAN ASSOCIATION OF BLOOD BANKS 8101 GLENBOOK ROAD BETHESDA MD 20814 362384118 501(C)(3) 18000 CONFERENCE SPONSOR STANFORD UNIVERSITY 40160 3373 HILLVIEW AVENUE PALO ALTO CA 94304 941156365 501(C)(3) 10000 RESEARCH FUND TRANSPLANT FINANCIAL COORDINATORS ASSOC PO BOX 28555 RICHMOND VA 23228 470832998 501(C)(3) 6500 CONFERENCE SPONSOR BE THE MATCH FOUNDATION 500 N 5TH ST MINNEAPOLIS MN 55401 411704734 501(C)(3) 2500000 FOUNDATION OPERATIONS 8 Procedure for Monitoring the Use of Grant Funds Inside U.S. Schedule I, Part I, Line 2 Before any check is cut for event or other sponsorship, the documentation around what the expenditure is for is reviewed and routed through approvals following our organization's chart of authority. X X X X X true true false false false false false true false Jeffrey Chell CEO - thru 6/2017 613150 0 177633 0 186620 0 24251 0 21833 0 1023487 0 66289 0 Dennis Confer Chief Medical Officer 362775 0 64525 0 64085 0 24251 0 31265 0 546901 0 0 0 Amy Ronneberg Chief Financial Officer 340347 0 69483 0 35063 0 24251 0 3909 0 473053 0 0 0 Karen Dodson Chief Operations Officer 302166 0 41089 0 40913 0 24251 0 21307 0 429726 0 0 0 Michael McCullough Chief Information Officer 263516 0 58961 0 54032 0 24251 0 28542 0 429302 0 0 0 Michael Boo CSO - thru 4/2017 299147 0 55749 0 45912 0 24251 0 21808 0 446867 0 0 0 Brian Lindberg Chief Legal Officer 287850 0 67909 0 36600 0 24251 0 28772 0 445382 0 0 0 John Miller VP & Sr. Medical Director 300815 0 45296 0 30026 0 24251 0 13386 0 413774 0 0 0 Linda Burns VP & Medical Dir., Research 281958 0 42804 0 21698 0 24251 0 21150 0 391861 0 0 0 Tracy Schmidt Chief Human Resources Officer 207099 0 45172 0 25588 0 24251 0 30773 0 332883 0 0 0 G Barry Huff Former Key Employee 0 0 0 0 212953 0 0 0 0 0 212953 0 0 0 Separation or Change-Of-Control Payment Schedule J, Part I, Line 4A G. Barry Huff left NMDP in September 2015. During calendar year 2016, he received separation payments of $212,953, which is reported in Schedule J, Part II, Column B(III). Supplemental Nonqualified Retirement Plan Schedule J, Part I, Line 4B The organization offers its officers, vice presidents, and directors a 457(B) deferred compensation plan (the "plan") created in accordance with applicable provisions of the internal revenue code. The plan permits employees to defer a portion of their salary until future years. The accumulated deferred compensation balance is not available to employees until termination, retirement, death, or unforeseeable emergency. All amounts of compensation deferred under the plan, and all income attributable to those amounts are (until paid or made available to the employee or other beneficiary) solely the property of the organization, and the organization has all the related rights of ownership (not restricted to the payment of benefits under the plan), subject only to the claim of the organization's general creditors. Participants' rights under the plan are equal to those of general creditors of the organization in an amount equal to the fair market value of the deferred account for each participant. The related assets and liabilities are reported at fair market value based on quoted market prices and are included within deferred compensation funds and deferred compensation payable in the consolidated statements of financial position. The organization offers a supplemental benefit plan (the "supplemental plan") for its officers, senior vice presidents and vice presidents. Each year, the supplemental plan contributes 14% of salary for the chief executive officer, 9% for other officers and senior vice presidents, and 4% for vice presidents. The supplemental plan is a flexible benefit plan allowing the supplemental plan participants to select from limited options, which include payment for spousal long-term care, and the balance as a contribution into the 457(B) deferred compensation plan (above) and/or an executive savings plan to supplement current basic and supplemental benefits. The executive savings plan replaced the capital accumulation plan effective January 1, 2013. All supplemental plan participants receive life insurance, disability salary continuation, long-term disability and long-term care insurance. The executive savings plan was created in accordance with applicable provisions of the Internal Revenue Code (IRC Sec 7702) whereby after-tax contributions into the plan accumulate without taxation and may be distributed without taxation using a combination of tax-free withdrawals and loans. Contributions will result in current income taxation. Plan balances are personally owned by the plan participants immediately and are not subject to a risk of forfeiture; as such, the plan assets are not recorded on the Organizations financial statements. The Supplemental Plan also provides for additional life insurance up to $750,000. Amounts paid in current year - 457(F) capital accumulation: - Jeffrey Chell $66,289 Non-Fixed Payments Schedule J, Part I, Line 7 Employee discretionary bonus and incentive plan payments are determined each year as part of the performance evaluation completed by human resources in collaboration with the individual's manager. A City of Minneapolis 416005375 2015-09-24 30000000 develop customized comp software false false false A 11690000 0 30000000 0 0 0 0 0 0 0 30000000 0 2015 false true false true A false false false false 0 false false false true A false false false false false false 0 false 0 false true A true Other Program Services Form 990, Part III, Line 4D Public Awareness - National Marrow Donor Program (NMDP) works with patient families, faith communities, corporations, colleges and universities, and other organizations to raise awareness about the opportunity to give patients hope by joining the registry, making a gift through Be the Match Foundation, and volunteering. In addition, NMDP is a leader in providing health care professionals with the education, resources and services they need to provide the best care for transplant patients. Delegation of Authority Form 990, Part VI, LINE 1 NMDP bylaws state: "The executive committee shall at all times include the chair of the board, the immediate past chair (when in office), the chair elect (when in office), the vice chair, the secretary, the chief executive officer, and any government representatives. All members of the executive committee shall be voting directors, except the chief executive officer and government representatives, who shall serve as non-voting ex officio members of the committee. The Executive Committee shall, to the extent determined by the Board of Directors, have the authority of the Board in the oversight of the business of the Corporation between meetings of the full Board and shall have such other authority and responsibilities as set forth in the Executive Committee Charter." The executive committee charter states: "The executive committee shall, to the extent determined by the board of directors, have the authority of the board in the oversight of the business of the corporation between meetings of the full board. The executive committee shall manage the business of the corporation and direct and coordinate the work activities of committees between meetings of the board. The executive committee shall also review key board-level policies and procedures on a periodic basis and recommend new or modified policies and initiatives. With the board, the executive committee is responsible for oversight of the strategic planning process, developing a calendar for board activities, and providing guidance to the board and corporation staff regarding the appropriate roles of each. The executive committee, in close coordination with the finance committee, shall monitor the financial integrity of operations, including evaluating performance against the corporation's budget and strategic and business plans. In addition, the executive committee shall represent the corporation in its interactions with other organizations, congress, federal agencies, participating centers, constituent groups, professional organizations, and the public." Reportable Relationships Form 990, Part VI, Line 2 The following individuals on the NMDP Board of Directors have a reportable business relationship: Melinda Caltabiano and Jennifer Jones Austin (Ms. Caltabiano and Ms. Jones Austin were, respectively, an employee of, and a director of, the same tax exempt organization during fiscal year 2017). The following officers of NMDP have a reportable business relationship: Jeffrey Chell and Amy Ronneberg (Mr. Chell and Ms. Ronneberg were both officers of CLR Insurance, Ltd. during fiscal year 2017). Form 990 Review Process Form 990, Part VI, Line 11B The organization contracted with the outside public accounting firm, Grant Thornton LLP, to prepare the Form 990. Preparing the details and supporting reports for the return is a collaborative effort among a small group of individuals in the financial reporting & compliance area of finance, internal audit and human resources. That work is then reviewed by the Manager of Financial Reporting prior to sending to Grant Thornton LLP; the Chief Legal Officer also reviews the governance sections and the Chief HR Officer reviews the compensation data prior to sending to Grant Thornton LLP. Once a draft is received back from Grant Thornton LLP, it is reviewed by the staff that pulled the details together, Vice President of Finance and Chief Financial Officer. A copy of the return is provided to the organization's Audit and finance committee and Board of Directors prior to filing. Conflict of Interest Policy Monitoring & Enforcement Form 990, Part VI, Line 12c The Conflict of Interest Policy states the following: "All Members must disclose to the applicable Organization's Board of Directors or Executive Committee all conflicts of interest and reportable relationships, and must annually complete and submit the Conflict of Interest Questionnaire which is required by this Policy. Whenever in the course of events a Member's circumstances change such that the Member knows or has reason to believe that the Member may have an actual or perceived conflict of interest, such Member shall promptly disclose the potential conflict to the applicable Organization's Board of Directors or Executive Committee. For the purposes of this Article, a Member may formally disclose a conflict or reportable relationship to the Chief Executive Officer (CEO) of NMDP, the BTMF Executive director and Senior Vice President (SVP) of Philanthropy, or the NMDP Chief Legal Officer (CLO), as applicable, who shall inform the applicable Organization's Board of Directors or Executive Committee for resolution. As noted herein, if the potential conflict involves a Director, that Director shall not participate in or vote upon such matters until the question of the existence of the conflict of interest has been resolved in accordance with this Policy. Likewise, an officer or key employee may not become substantially involved in decision-making involving any covered litigation, contract or transaction until the resolution of the matter in accordance with this Policy. The existence of an actual or potential conflict of interest turns on the specific facts and circumstances in each case. If a Member has an interest which may conflict with those of NMDP and/or BTMF, he or she must immediately disclose the matters and discuss them fully and frankly with the applicable Organization's full Board or the Executive Committee, as set forth in detail below. A Member must not participate in any matter in which that the Member may have an actual or potential conflict of interest without the express approval of the applicable Organization's Board of Directors or its Executive Committee." Process for Determining Compensation Form 990, Part VI, Lines 15A & 15B The NMDP Bylaws state: "The Compensation Committee shall be comprised only of Voting Directors and shall include the Chair of the Board and at least one (1) non-officer Board member as voting committee members. The Compensation Committee shall review and evaluate the overall compensation and benefit structure of the Corporation and shall have such other authority and responsibilities as set forth in the Compensation Committee Charter." The Compensation Committee Charter states: "The Compensation Committee shall review and evaluate the overall compensation and benefit structure of the Corporation. The Compensation Committee shall conduct the Chief Executive Officer performance evaluation and make Chief Executive Officer compensation and benefit recommendations to the Executive Committee. In making the Chief Executive Officer's compensation and benefit recommendations, the Committee shall utilize, among other things, comparability data for compliance with IRS Intermediate Sanction rules. On a periodic basis, the Compensation Committee shall obtain comparability data from an independent compensation consultant. In addition, the Compensation Committee shall advise the Chief Executive Officer in the evaluation and compensation of and benefits for senior corporation employees, as well as the President of any affiliate of the Corporation reporting to the Chief Executive Officer." How Documents Are Made Available to the Public Form 990, Part VI, Line 19 The conflict of interest policy, articles of incorporation and consolidated audited financial statements are available to the public upon request. Summary financial statements are also included in our annual report, which is mailed to key stakeholders and posted on our website. Additionally, articles of incorporation are available through the MN Office of the Secretary of State, and consolidated audited financial statements may be obtained at the MN Office of the Attorney General. Hours for Related Organization Form 990, Part VII, Line 1A, Column B The hours listed on the 990 Part VII are based on a 50 hour week that these individuals devoted to NMDP and BTMF in total during the year. Compensation Form 990, Part VII, Section A, Line 1A, Column D NMDP provided a Form 1099-MISC to David Porter for consulting services provided as chair of the CIBMTR data safety monitoring board meetings during calendar year 2016. Other Changes in Net Assets or fund balances Form 990, Part XI, Line 9 In Fiscal year 2016, NMDP started a new company - Be the Match BioTherapies, LLC, a disregarded subsidiary. During the second year of operations, NMDP made capital contributions to this organization. capital contributions $5,800,000. BE THE MATCH BIOTHERAPIES LLC 500 N 5TH ST MINNEAPOLIS MN 554011206 811241889 CELL THERAPY MN -1608488 5649459 NMDP BE THE MATCH FOUNDATION 500 N 5th ST MINNEAPOLIS MN 554011206 411704734 FUNDRAISING MN 501(c)(3) 07 NMDP true CLR INSURANCE LTD 62 FORUM LN 3RD FL KY1-1203 PO Box Grand Cayman CJ KY1-1203 840865803 CAPTIVE INSURance CJ NMDP C Corp 996901 2142018 1.00000 true BE THE MATCH BIOTHERAPIES SERVICES LLC 500 N 5th ST MINNEAPOLIS MN 554011206 811248190 CELLular THERAPY MN NMDP C Corp 0 1106546 1.00000 true true true true false false false false false false false false false false true true false true true false BE THE MATCH BIOTHERAPIES SERVICES LLC A 325702 FMV BE THE MATCH FOUNDATION B 2500000 COST BE THE MATCH FOUNDATION C 4672060 COST BE THE MATCH FOUNDATION N 147131 COST BE THE MATCH FOUNDATION O 804439 COST BE THE MATCH BIOTHERAPIES SERVICES LLC R 973876 COST NATIONAL MARROW DONOR PROGRA 500 N 5th St MINNEAPOLIS MN 55401 840865803 0 426631 426631 364656781 365083412 1000000 250000 0 0 0 BE THE MATCH FOUNDATION 500 N 5th St MINNEAPOLIS MN 55401 411704734 0 0 0 12699664 12699664 784983 196246 0 0 0